Qure.ai

Mumbai, India  All India companies → — Founded 2016
Series D — $157M

Products

Qure.ai QXR
Qure.ai
Clinical Decision Support & Reference
Qure.ai QXR is an AI-powered solution for chest X-ray interpretation, designed to assist radiologists, pulmonologists, and ER physicians in diagnosing various conditions.

See all 1 product →

About Qure.ai

Qure.ai is a leading health technology company that leverages artificial intelligence and deep learning to enhance medical imaging diagnostics, aiming to make healthcare more accessible and affordable globally. Founded in 2016, the company develops AI-powered solutions for interpreting X-rays, CT scans, and ultrasounds, which can assist physicians in routine diagnosis and treatment. Their technology helps identify and localize a wide range of abnormalities, including signs of tuberculosis, lung cancer, heart failure, and stroke, enabling faster diagnosis and more timely treatment.

Qure.ai’s solutions are designed to support emergency room physicians, family medicine practitioners, and radiologists by providing a ‘second opinion’ and automating routine work, allowing clinicians to dedicate more time to patient care. The company’s flagship product, qXR, for instance, identifies and localizes various conditions in chest X-rays with high accuracy. With deployments in over 90 countries and 3000+ sites, Qure.ai is at the forefront of transforming diagnostics in both acute and chronic ailments, with a mission to reach a billion patients through its solutions.

Focus Areas

AI-powered radiology interpretation medical imaging diagnostics deep learning lung health musculoskeletal health cardiovascular health neurocritical health tuberculosis detection lung cancer detection stroke detection heart failure detection

Business Intelligence

Key InvestorsLightspeed, 360 ONE Asset, Merck Global Health Innovation Fund, Kae Capital, Novo Holdings, HealthQuad, MassMutual Ventures, Peak XV Partners, Bill & Melinda Gates Foundation, Crane Venture Partners, 4point0 Health Ventures, TeamFund, C-CAMP, ACT Grants, SBRI Healthcare, Arbor Ventures
PartnershipsAstraZeneca, Medtronic, Johnson & Johnson, NHS, StopTB, vRad
Acquisitionsunknown
TechnologyDeep learning technology for automated interpretation of radiology examinations (X-rays, CTs, Ultrasounds). Cloud-native and edge computing approaches are implied by global deployments and integration into clinical workflows.
FDA Clearances26 cleared products (estimated)

Products by Qure.ai

1 product in the directory

Qure.ai QXR
Qure.ai
Clinical Decision Support & Reference
Qure.ai QXR is an AI-powered solution for chest X-ray interpretation, designed to assist radiologists, pulmonologists, and ER physicians in diagnosing various conditions.

Reviews & Opinions

No web reviews on file yet for Qure.ai. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Qure.ai.

Loading videos...

Videos load interactively. If none appear, search YouTube for Qure.ai →

View all on YouTube

Press & Coverage

HIT Consultant
Qure.ai Gets $65M Series D Funding to Expand Healthcare AI
Qure.ai announced the completion of a $65 million Series D funding round, led by Lightspeed and 360 ONE Asset, to accelerate expansion into the US market and other geographies, increase investment into foundational AI models, and enable complementary med-tech company acquisitions.
2024-09
AuntMinnie.com
Qure.ai secures FDA clearance for chest x-ray CAD software
Qure.ai received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for qXR-Detect, a computer-assisted detection (CAD) solution for plain film chest x-rays, bringing its total FDA-cleared indications to 26 across nine x-ray and CT products.
2026-02
Diagnostic and Interventional Cardiology
FDA Clears Qure.ai's New AI Solution for Early Detection of Large Vessel Occlusions
Qure.ai announced FDA clearance for its qER-CTA product, an AI tool designed to help detect large vessel occlusions (LVOs) in the brain, marking its 19th regulatory approval in the United States.
2025-10
Cureus
Revolutionizing Healthcare: Qure.AI's Innovations in Medical Diagnosis and Treatment
This article highlights Qure.ai's innovations in medical diagnosis and treatment, particularly focusing on its qXR software for chest X-ray analysis and its effectiveness in detecting conditions like heart failure and lung nodules.
2024-06
Qure.ai
Qure.ai announces strategic investment by Merck Global Health Innovation Fund
Merck Global Health Innovation Fund made a strategic investment in Qure.ai as part of its Series D round, with funds directed towards investing in foundation models for AI in imaging and expanding the geographical reach of Qure.ai's solutions.
2024-06
Qure.ai
Qure.ai raises $40 Million from healthcare investors Novo Holdings and HealthQuad
Qure.ai secured $40 million in a funding round led by Novo Holdings and HealthQuad, supported by existing investor Mass Mutual Ventures, to accelerate market expansion into the global market and support new product development.
2022-03
Cision PR Newswire
Qure.ai's Clinical Decision Support System Aira Among World's First to Win Class IIb CE Certification
Qure.ai's Clinical Decision Support System Aira received Class IIb CE Certification, a significant regulatory milestone for its AI-powered healthcare solutions.
2026-09
hrtoday.in
Qure.ai Appoints Mihir Bhanushali as Executive Vice President, Global Health, to Lead AI-Powered Healthcare Expansion Across Low- and Middle-Income Countries
Qure.ai appointed Mihir Bhanushali as Executive Vice President, Global Health, to lead the expansion of its AI-powered healthcare solutions in low- and middle-income countries.
2026-08
No FAQs available yet for this company.

Related Companies

Health Fidelity provides AI-powered solutions designed to help healthcare organizations, particularly those involved in risk adjustment and quality improvement programs, accurately capture and manage patient data. Their tools leverage natural language processing (NLP) and machine learning to extract critical information from unstructured clinical notes, such as physician documentation, to ensure comprehensive and accurate risk scoring. […]

EXF Health, a vertical of Exafluence, focuses on enhancing healthcare organizations by strengthening their health IT infrastructure and improving their analytics and data maturity. The company leverages best-in-class AI/ML tools and techniques to add continuous value to all healthcare participants. For healthcare payers, EXF Health offers executive decision boards that provide actionable insights to track […]

Kinvectum AB is a Swedish company focused on developing AI tools for the healthcare sector, specifically targeting physicians and healthcare providers. Their flagship product, Internet PM, is an informational clinical support tool designed to assist medical professionals in searching for and evaluating medical information from trusted sources. The platform aims to enhance clinical decision-making by […]

Tortus AI is an innovative UK-based company dedicated to transforming healthcare by reducing administrative burdens on physicians through advanced AI. Their flagship product, O.S.L.E.R. (Operating System Leverage in Electronic Records), acts as an AI co-pilot, utilizing ambient voice technology to listen to clinician-patient consultations. It then automatically transcribes, structures, and drafts clinical notes, letters, referrals, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.